0.00 / 0.00%
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 19 2014 13:20 GMT.
ADA:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)

Total returns on £1000

Fund / BenchmarkChange
PriceAdams (Ordinary Share)+71.43%
Adams (Ordinary Share)+1.75%
Morningstar's BenchmarkMSCI EUROPE/BIOTECHNOLOGY+18.62%
As of Nov 17 2014.

Adams PLC summary

Shares outstanding23.09m
Market cap4.20 EUR
Total assets0.30 EUR
Total expense ratio0.00%
Day high--
Day low--
Previous close0.18
Average volume5.04k
YTD Change+63.64 %
Beta-0.2098 %
Diluted NAV (est)0.01
Diluted NAV (last pub)--
Premium/Discount+999.00 %
Gearing+100.00 %
52-week range
Sep 11 2014
Sep 17 2014

As of last trade ADA:LSE traded at 0.18, 45.45% below its 52-week high of 0.33, set on Sep 17, 2014.

Data delayed at least 15 minutes, as of Nov 19 2014 13:20 GMT.

RNS Company announcements

Result of AGM
Holding(s) in Company
Stmnt re Share Price Movement
Final Results
Holding(s) in Company


Management group(s)Carpathian Asset Management Ltd
AIC sectorSector Specialist: Biotechnology/Life Sciences
Launch date26 Jul 2005
Share typeOrdinary Share
Base currencyEUR


To create value for shareholders by acquiring a direct and/or an indirect interest in projects and assets in the UK and Europe biotechnology sectors.

Management & contract fees

The manager will be paid a variable fee starting at GBP 1.86m p.a. and decreasing over the year as core assets are sold. The fee is expected to reduce at an annualised rate of 22% p.a. The adviser is entitled to a sales fee of 0.5% of the gross property sale value of each asset within the core portfolio that is sold. The manager will also receive a performance fee equal to 10% of any return above a distribution to shareholders in excess of a EUR 0.1725 per share hurdle and 25% of any returns to shareholders above a EUR 0.345 per share hurdle.


Div yield
Div ex-date
Div pay-date

Managed by

Director Managed Start : 28 Jul 2008
Data delayed at least 15 minutes, as of Nov 19 2014 13:20 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.